contraindicaciones tirzepatide Ki Contraindicaciones De La Tirzepatida

Only 4.2% of participants discontinued due to side effects after week 24, indicating that side effects become manageable or resolve entirely for the vast majority who continue treatment

The dose is then increased by 0.6 mg each week until you reach the target dose of 3.0 mg daily for weight loss

Clinical trial data demonstrates: 1015% total body weight loss over 1218 months Reduction in HbA1c Improved blood pressure Reduced visceral fat Improved mobility Early weight loss response within 1216 weeks predicts long-term success

Its approved for treating type 2 diabetes and for losing weight in eligible adults

You need a BMI of 30 or greater , or a BMI of 27 or greater with at least one weight-related comorbidity such as type 2 diabetes, hypertension, sleep apnea, or high cholesterol